|3May 21, 6:54 PM ET

Deer X & Co. L.P. 3

3 · Hinge Health, Inc. · Filed May 21, 2025

Insider Transaction Report

Form 3
Period: 2025-05-21
Holdings
  • Series C Preferred Stock

    (indirect: See footnote)
    Common Stock (4,511,338 underlying)
  • Series D Preferred Stock

    (indirect: See footnote)
    Common Stock (322,435 underlying)
Footnotes (4)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
  • [F2]Deer X & Co. Ltd. is the general partner of Deer X & Co. L.P., which is the general partner of each of Bessemer Venture Partners X L.P. ("Bessemer X") and Bessemer Venture Partners X Institutional L.P. ("Bessemer X International," and together with Bessemer X, the "Bessemer Entities"). As a result, each of Deer X & Co. Ltd. and Deer X & Co. L.P. may be deemed to share beneficial ownership of the securities held by the Bessemer Entities.
  • [F3]Consists of (i) 2,326,948 shares held by Bessemer X and (ii) 2,184,390 shares held by Bessemer X International.
  • [F4]Consists of (i) 166,312 shares held by Bessemer X and (ii) 156,123 shares held by Bessemer X International.

Documents

1 file
  • 3
    ownership.xmlPrimary

    3